Gene · 56848
Papers2,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. | Cells | 2023 | 37759552 | PubTator, text mining | PubMed |
| Sphingosine kinase 1 is involved in triglyceride breakdown by maintaining lysosomal integrity in brown adipocytes. | J Lipid Res | 2023 | 37751791 | PubTator, text mining | PubMed |
| MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1. | World J Gastrointest Oncol | 2023 | 37746648 | PubTator, text mining | PubMed |
| Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury. | Front Med (Lausanne) | 2023 | 37746079 | PubTator, text mining | PubMed |
| Enhanced selective capture of phosphomonoester lipids enabling highly sensitive detection of sphingosine 1-phosphate. | Anal Bioanal Chem | 2023 | 37736841 | PubTator, text mining | PubMed |
Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients. | Front Immunol | 2023 | 37727789 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Physiochemical characteristics and sensory properties of plant protein isolates-konjac glucomannan compound gels. | Food Sci Nutr | 2023 | 37701223 | PubTator, text mining | PubMed |
| Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension. | Circ Res | 2023 | 37698017 | PubTator, text mining | PubMed |
| The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro. | Cancers (Basel) | 2023 | 37686550 | PubTator, text mining | PubMed |
| The role and implication of autophagy in cholangiocarcinoma. | Cell Death Discov | 2023 | 37666811 | PubTator, text mining | PubMed |
| Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19. | Front Immunol | 2023 | 37662924 | PubTator, text mining | PubMed |
| Adipokines in atherosclerosis: unraveling complex roles. | Front Cardiovasc Med | 2023 | 37645520 | PubTator, text mining | PubMed |
| Lipid metabolic vulnerabilities of multiple myeloma. | Clin Exp Med | 2023 | 37639069 | PubTator, text mining | PubMed |
| HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France). | Pharmaceuticals (Basel) | 2023 | 37631033 | PubTator, text mining | PubMed |
| Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm? | Int J Mol Sci | 2023 | 37628815 | PubTator, text mining | PubMed |
| Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation. | J Ovarian Res | 2023 | 37620938 | PubTator, text mining | PubMed |
| Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth. | Cell Death Dis | 2023 | 37604912 | PubTator, text mining | PubMed |
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. | BMC Cancer | 2023 | 37587449 | PubTator, text mining | PubMed |
| Design, synthesis, antitumor activity, and molecular dynamics simulations of novel sphingosine kinase 2 inhibitors. | Bioorg Med Chem | 2023 | 37586181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56848/papers?page=9